nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CYP2B6—Diphenhydramine—allergic rhinitis	0.0307	0.0657	CbGbCtD
Nilotinib—CYP2C9—Desloratadine—allergic rhinitis	0.0283	0.0604	CbGbCtD
Nilotinib—ABCB1—Desloratadine—allergic rhinitis	0.0274	0.0587	CbGbCtD
Nilotinib—CYP2D6—Desloratadine—allergic rhinitis	0.0259	0.0553	CbGbCtD
Nilotinib—ABCG2—Hydrocortisone—allergic rhinitis	0.0243	0.052	CbGbCtD
Nilotinib—CYP2C8—Montelukast—allergic rhinitis	0.0233	0.0498	CbGbCtD
Nilotinib—CYP2C8—Loratadine—allergic rhinitis	0.0233	0.0498	CbGbCtD
Nilotinib—CYP3A4—Flunisolide—allergic rhinitis	0.0164	0.0351	CbGbCtD
Nilotinib—CYP2C9—Montelukast—allergic rhinitis	0.0162	0.0347	CbGbCtD
Nilotinib—CYP2C9—Diphenhydramine—allergic rhinitis	0.0162	0.0347	CbGbCtD
Nilotinib—CYP2C9—Loratadine—allergic rhinitis	0.0162	0.0347	CbGbCtD
Nilotinib—ABCB1—Loratadine—allergic rhinitis	0.0158	0.0337	CbGbCtD
Nilotinib—CYP3A4—Olopatadine—allergic rhinitis	0.0155	0.033	CbGbCtD
Nilotinib—ABCG2—Dexamethasone—allergic rhinitis	0.0151	0.0323	CbGbCtD
Nilotinib—CYP2D6—Loratadine—allergic rhinitis	0.0148	0.0317	CbGbCtD
Nilotinib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0148	0.0317	CbGbCtD
Nilotinib—ABCB1—Methylprednisolone—allergic rhinitis	0.0144	0.0308	CbGbCtD
Nilotinib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0129	0.0277	CbGbCtD
Nilotinib—CYP2B6—Dexamethasone—allergic rhinitis	0.0106	0.0227	CbGbCtD
Nilotinib—CYP3A4—Loratadine—allergic rhinitis	0.00944	0.0202	CbGbCtD
Nilotinib—CYP3A4—Montelukast—allergic rhinitis	0.00944	0.0202	CbGbCtD
Nilotinib—ABCB1—Betamethasone—allergic rhinitis	0.00937	0.02	CbGbCtD
Nilotinib—ABCB1—Prednisolone—allergic rhinitis	0.00925	0.0198	CbGbCtD
Nilotinib—ABCB1—Hydrocortisone—allergic rhinitis	0.00877	0.0187	CbGbCtD
Nilotinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.00864	0.0185	CbGbCtD
Nilotinib—CYP2C8—Dexamethasone—allergic rhinitis	0.00805	0.0172	CbGbCtD
Nilotinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00654	0.014	CbGbCtD
Nilotinib—CYP2C9—Dexamethasone—allergic rhinitis	0.00562	0.012	CbGbCtD
Nilotinib—CYP3A4—Betamethasone—allergic rhinitis	0.00561	0.012	CbGbCtD
Nilotinib—CYP3A4—Prednisolone—allergic rhinitis	0.00554	0.0118	CbGbCtD
Nilotinib—ABCB1—Dexamethasone—allergic rhinitis	0.00545	0.0117	CbGbCtD
Nilotinib—CA6—saliva—allergic rhinitis	0.00542	0.0429	CbGeAlD
Nilotinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00525	0.0112	CbGbCtD
Nilotinib—CYP2D6—Dexamethasone—allergic rhinitis	0.00514	0.011	CbGbCtD
Nilotinib—CA6—ear—allergic rhinitis	0.00495	0.0393	CbGeAlD
Nilotinib—CA3—ear—allergic rhinitis	0.00469	0.0372	CbGeAlD
Nilotinib—MAPK8—exocrine gland—allergic rhinitis	0.00381	0.0302	CbGeAlD
Nilotinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00327	0.00698	CbGbCtD
Nilotinib—CA6—exocrine gland—allergic rhinitis	0.00274	0.0217	CbGeAlD
Nilotinib—CDC42BPB—respiratory system—allergic rhinitis	0.0022	0.0174	CbGeAlD
Nilotinib—EPHA8—eye—allergic rhinitis	0.00218	0.0172	CbGeAlD
Nilotinib—CDC42BPB—eye—allergic rhinitis	0.00201	0.0159	CbGeAlD
Nilotinib—MAPK8—respiratory system—allergic rhinitis	0.00199	0.0157	CbGeAlD
Nilotinib—EPHA3—eye—allergic rhinitis	0.0019	0.0151	CbGeAlD
Nilotinib—MAPK8—eye—allergic rhinitis	0.00181	0.0144	CbGeAlD
Nilotinib—CDC42BPB—bronchus—allergic rhinitis	0.00181	0.0143	CbGeAlD
Nilotinib—TIE1—respiratory system—allergic rhinitis	0.00172	0.0136	CbGeAlD
Nilotinib—MAPK8—epithelium—allergic rhinitis	0.00166	0.0132	CbGeAlD
Nilotinib—MAPK8—bronchus—allergic rhinitis	0.00163	0.013	CbGeAlD
Nilotinib—CDC42BPB—trachea—allergic rhinitis	0.00162	0.0129	CbGeAlD
Nilotinib—KIT—exocrine gland—allergic rhinitis	0.00159	0.0126	CbGeAlD
Nilotinib—MAPK8—skin of body—allergic rhinitis	0.00158	0.0125	CbGeAlD
Nilotinib—MAP4K1—bronchus—allergic rhinitis	0.00148	0.0118	CbGeAlD
Nilotinib—TIE1—epithelium—allergic rhinitis	0.00144	0.0114	CbGeAlD
Nilotinib—CA3—respiratory system—allergic rhinitis	0.00135	0.0107	CbGeAlD
Nilotinib—EPHB3—bronchus—allergic rhinitis	0.00135	0.0107	CbGeAlD
Nilotinib—MAPK14—respiratory system—allergic rhinitis	0.00126	0.00999	CbGeAlD
Nilotinib—FGR—respiratory system—allergic rhinitis	0.00126	0.00995	CbGeAlD
Nilotinib—HCK—bronchus—allergic rhinitis	0.00124	0.00981	CbGeAlD
Nilotinib—EPHB3—trachea—allergic rhinitis	0.00121	0.00959	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Flunisolide—allergic rhinitis	0.0012	0.298	CbGdCrCtD
Nilotinib—EPHB4—respiratory system—allergic rhinitis	0.0012	0.00947	CbGeAlD
Nilotinib—EPHA2—respiratory system—allergic rhinitis	0.00117	0.00929	CbGeAlD
Nilotinib—CDC42BPB—lung—allergic rhinitis	0.00117	0.00924	CbGeAlD
Nilotinib—TEK—respiratory system—allergic rhinitis	0.00114	0.00907	CbGeAlD
Nilotinib—EPHA4—bronchus—allergic rhinitis	0.00113	0.00892	CbGeAlD
Nilotinib—HCK—trachea—allergic rhinitis	0.00111	0.00881	CbGeAlD
Nilotinib—EPHA3—lung—allergic rhinitis	0.0011	0.00876	CbGeAlD
Nilotinib—CA7—trachea—allergic rhinitis	0.00109	0.00862	CbGeAlD
Nilotinib—MAPK8—lung—allergic rhinitis	0.00105	0.00836	CbGeAlD
Nilotinib—MAPK14—epithelium—allergic rhinitis	0.00105	0.00835	CbGeAlD
Nilotinib—MAPK14—bronchus—allergic rhinitis	0.00104	0.00822	CbGeAlD
Nilotinib—PDGFRA—respiratory system—allergic rhinitis	0.00104	0.00821	CbGeAlD
Nilotinib—LCK—bronchus—allergic rhinitis	0.00103	0.00819	CbGeAlD
Nilotinib—EPHA4—trachea—allergic rhinitis	0.00101	0.00801	CbGeAlD
Nilotinib—MAPK14—skin of body—allergic rhinitis	0.001	0.00794	CbGeAlD
Nilotinib—EPHB4—epithelium—allergic rhinitis	0.000999	0.00792	CbGeAlD
Nilotinib—EPHB4—bronchus—allergic rhinitis	0.000984	0.0078	CbGeAlD
Nilotinib—EPHA2—epithelium—allergic rhinitis	0.00098	0.00777	CbGeAlD
Nilotinib—EPHA2—bronchus—allergic rhinitis	0.000965	0.00765	CbGeAlD
Nilotinib—MAP4K1—lung—allergic rhinitis	0.000958	0.00759	CbGeAlD
Nilotinib—CA12—respiratory system—allergic rhinitis	0.000956	0.00758	CbGeAlD
Nilotinib—TEK—epithelium—allergic rhinitis	0.000956	0.00758	CbGeAlD
Nilotinib—CA2—exocrine gland—allergic rhinitis	0.000943	0.00748	CbGeAlD
Nilotinib—TEK—bronchus—allergic rhinitis	0.000941	0.00746	CbGeAlD
Nilotinib—LCK—trachea—allergic rhinitis	0.000928	0.00736	CbGeAlD
Nilotinib—TIE1—lung—allergic rhinitis	0.000914	0.00724	CbGeAlD
Nilotinib—CSF1R—respiratory system—allergic rhinitis	0.000912	0.00723	CbGeAlD
Nilotinib—EPHB6—bronchus—allergic rhinitis	0.0009	0.00713	CbGeAlD
Nilotinib—EPHB4—trachea—allergic rhinitis	0.000883	0.007	CbGeAlD
Nilotinib—BRAF—lung—allergic rhinitis	0.000876	0.00695	CbGeAlD
Nilotinib—CA12—eye—allergic rhinitis	0.000874	0.00693	CbGeAlD
Nilotinib—EPHB3—lung—allergic rhinitis	0.000869	0.00689	CbGeAlD
Nilotinib—EPHB6—skin of body—allergic rhinitis	0.000869	0.00689	CbGeAlD
Nilotinib—EPHA2—trachea—allergic rhinitis	0.000866	0.00687	CbGeAlD
Nilotinib—CSF1R—eye—allergic rhinitis	0.000834	0.00661	CbGeAlD
Nilotinib—KIT—respiratory system—allergic rhinitis	0.000828	0.00657	CbGeAlD
Nilotinib—PDGFRB—respiratory system—allergic rhinitis	0.000809	0.00641	CbGeAlD
Nilotinib—EPHB6—trachea—allergic rhinitis	0.000808	0.0064	CbGeAlD
Nilotinib—HCK—lung—allergic rhinitis	0.000799	0.00633	CbGeAlD
Nilotinib—ABL2—lung—allergic rhinitis	0.000794	0.00629	CbGeAlD
Nilotinib—MAP2K5—bronchus—allergic rhinitis	0.000769	0.0061	CbGeAlD
Nilotinib—PDGFRA—trachea—allergic rhinitis	0.000766	0.00607	CbGeAlD
Nilotinib—CA1—respiratory system—allergic rhinitis	0.000758	0.00601	CbGeAlD
Nilotinib—CSF1R—bronchus—allergic rhinitis	0.000751	0.00595	CbGeAlD
Nilotinib—PDGFRB—eye—allergic rhinitis	0.000739	0.00586	CbGeAlD
Nilotinib—EPHA4—lung—allergic rhinitis	0.000726	0.00576	CbGeAlD
Nilotinib—CSF1R—skin of body—allergic rhinitis	0.000725	0.00575	CbGeAlD
Nilotinib—ABL1—respiratory system—allergic rhinitis	0.000721	0.00572	CbGeAlD
Nilotinib—CA3—lung—allergic rhinitis	0.000717	0.00568	CbGeAlD
Nilotinib—CA12—trachea—allergic rhinitis	0.000707	0.0056	CbGeAlD
Nilotinib—KIT—epithelium—allergic rhinitis	0.000692	0.00549	CbGeAlD
Nilotinib—CA1—eye—allergic rhinitis	0.000692	0.00549	CbGeAlD
Nilotinib—MAP2K5—trachea—allergic rhinitis	0.000691	0.00548	CbGeAlD
Nilotinib—KIT—bronchus—allergic rhinitis	0.000682	0.0054	CbGeAlD
Nilotinib—PDGFRB—epithelium—allergic rhinitis	0.000676	0.00536	CbGeAlD
Nilotinib—CSF1R—trachea—allergic rhinitis	0.000674	0.00534	CbGeAlD
Nilotinib—MAPK14—lung—allergic rhinitis	0.000669	0.00531	CbGeAlD
Nilotinib—LCK—lung—allergic rhinitis	0.000667	0.00528	CbGeAlD
Nilotinib—FGR—lung—allergic rhinitis	0.000667	0.00528	CbGeAlD
Nilotinib—PDGFRB—bronchus—allergic rhinitis	0.000666	0.00528	CbGeAlD
Nilotinib—ABL1—eye—allergic rhinitis	0.000659	0.00522	CbGeAlD
Nilotinib—KIT—skin of body—allergic rhinitis	0.000658	0.00522	CbGeAlD
Nilotinib—PDGFRB—skin of body—allergic rhinitis	0.000643	0.0051	CbGeAlD
Nilotinib—EPHB4—lung—allergic rhinitis	0.000635	0.00503	CbGeAlD
Nilotinib—EPHA2—lung—allergic rhinitis	0.000623	0.00493	CbGeAlD
Nilotinib—KIT—trachea—allergic rhinitis	0.000612	0.00485	CbGeAlD
Nilotinib—TEK—lung—allergic rhinitis	0.000607	0.00481	CbGeAlD
Nilotinib—PDGFRB—trachea—allergic rhinitis	0.000598	0.00474	CbGeAlD
Nilotinib—ABL1—bronchus—allergic rhinitis	0.000594	0.0047	CbGeAlD
Nilotinib—CA4—respiratory system—allergic rhinitis	0.000592	0.00469	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Methylprednisolone—allergic rhinitis	0.000587	0.146	CbGdCrCtD
Nilotinib—EPHB6—lung—allergic rhinitis	0.00058	0.0046	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Betamethasone—allergic rhinitis	0.000578	0.143	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Dexamethasone—allergic rhinitis	0.000578	0.143	CbGdCrCtD
Nilotinib—ABL1—skin of body—allergic rhinitis	0.000573	0.00454	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Triamcinolone—allergic rhinitis	0.000565	0.14	CbGdCrCtD
Nilotinib—PDGFRA—lung—allergic rhinitis	0.00055	0.00436	CbGeAlD
Nilotinib—ABL1—trachea—allergic rhinitis	0.000533	0.00422	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Prednisolone—allergic rhinitis	0.000523	0.13	CbGdCrCtD
Nilotinib—CA12—lung—allergic rhinitis	0.000508	0.00403	CbGeAlD
Nilotinib—MAP2K5—lung—allergic rhinitis	0.000496	0.00393	CbGeAlD
Nilotinib—CA2—respiratory system—allergic rhinitis	0.000491	0.00389	CbGeAlD
Nilotinib—CSF1R—lung—allergic rhinitis	0.000484	0.00384	CbGeAlD
Nilotinib—CA2—eye—allergic rhinitis	0.000449	0.00356	CbGeAlD
Nilotinib—KIT—lung—allergic rhinitis	0.00044	0.00349	CbGeAlD
Nilotinib—CA4—trachea—allergic rhinitis	0.000438	0.00347	CbGeAlD
Nilotinib—PDGFRB—lung—allergic rhinitis	0.00043	0.00341	CbGeAlD
Nilotinib—CYP2B6—respiratory system—allergic rhinitis	0.00042	0.00333	CbGeAlD
Nilotinib—CA2—epithelium—allergic rhinitis	0.00041	0.00325	CbGeAlD
Nilotinib—CA2—bronchus—allergic rhinitis	0.000404	0.0032	CbGeAlD
Nilotinib—CA1—lung—allergic rhinitis	0.000402	0.00319	CbGeAlD
Nilotinib—CA2—skin of body—allergic rhinitis	0.00039	0.00309	CbGeAlD
Nilotinib—ABL1—lung—allergic rhinitis	0.000383	0.00304	CbGeAlD
Nilotinib—CA2—trachea—allergic rhinitis	0.000363	0.00288	CbGeAlD
Nilotinib—CYP2B6—bronchus—allergic rhinitis	0.000345	0.00274	CbGeAlD
Nilotinib—CYP2B6—skin of body—allergic rhinitis	0.000333	0.00264	CbGeAlD
Nilotinib—CA4—lung—allergic rhinitis	0.000314	0.00249	CbGeAlD
Nilotinib—CA2—lung—allergic rhinitis	0.000261	0.00207	CbGeAlD
Nilotinib—ABCG2—lung—allergic rhinitis	0.000241	0.00191	CbGeAlD
Nilotinib—ABCB1—respiratory system—allergic rhinitis	0.000224	0.00178	CbGeAlD
Nilotinib—CYP2B6—lung—allergic rhinitis	0.000223	0.00177	CbGeAlD
Nilotinib—ABCB1—epithelium—allergic rhinitis	0.000187	0.00149	CbGeAlD
Nilotinib—ABCB1—trachea—allergic rhinitis	0.000166	0.00131	CbGeAlD
Nilotinib—ABCB1—lung—allergic rhinitis	0.000119	0.000944	CbGeAlD
Nilotinib—Bradycardia—Dexamethasone—allergic rhinitis	9.98e-05	0.000374	CcSEcCtD
Nilotinib—Haemoglobin—Betamethasone—allergic rhinitis	9.85e-05	0.000369	CcSEcCtD
Nilotinib—Haemoglobin—Dexamethasone—allergic rhinitis	9.85e-05	0.000369	CcSEcCtD
Nilotinib—Haemorrhage—Dexamethasone—allergic rhinitis	9.8e-05	0.000367	CcSEcCtD
Nilotinib—Haemorrhage—Betamethasone—allergic rhinitis	9.8e-05	0.000367	CcSEcCtD
Nilotinib—Angiopathy—Methylprednisolone—allergic rhinitis	9.78e-05	0.000367	CcSEcCtD
Nilotinib—Immune system disorder—Methylprednisolone—allergic rhinitis	9.74e-05	0.000365	CcSEcCtD
Nilotinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	9.71e-05	0.000364	CcSEcCtD
Nilotinib—Arrhythmia—Triamcinolone—allergic rhinitis	9.65e-05	0.000362	CcSEcCtD
Nilotinib—Vision blurred—Prednisolone—allergic rhinitis	9.64e-05	0.000361	CcSEcCtD
Nilotinib—Arrhythmia—Methylprednisolone—allergic rhinitis	9.63e-05	0.000361	CcSEcCtD
Nilotinib—Vomiting—Montelukast—allergic rhinitis	9.6e-05	0.00036	CcSEcCtD
Nilotinib—Rash—Montelukast—allergic rhinitis	9.52e-05	0.000357	CcSEcCtD
Nilotinib—Dermatitis—Montelukast—allergic rhinitis	9.51e-05	0.000356	CcSEcCtD
Nilotinib—Ill-defined disorder—Prednisolone—allergic rhinitis	9.49e-05	0.000356	CcSEcCtD
Nilotinib—Headache—Montelukast—allergic rhinitis	9.46e-05	0.000355	CcSEcCtD
Nilotinib—Visual impairment—Dexamethasone—allergic rhinitis	9.45e-05	0.000354	CcSEcCtD
Nilotinib—Visual impairment—Betamethasone—allergic rhinitis	9.45e-05	0.000354	CcSEcCtD
Nilotinib—Mental disorder—Methylprednisolone—allergic rhinitis	9.44e-05	0.000354	CcSEcCtD
Nilotinib—Erythema—Triamcinolone—allergic rhinitis	9.4e-05	0.000353	CcSEcCtD
Nilotinib—Erythema—Methylprednisolone—allergic rhinitis	9.38e-05	0.000352	CcSEcCtD
Nilotinib—Malnutrition—Methylprednisolone—allergic rhinitis	9.38e-05	0.000352	CcSEcCtD
Nilotinib—Ill-defined disorder—Hydrocortisone—allergic rhinitis	9.27e-05	0.000347	CcSEcCtD
Nilotinib—Malaise—Prednisolone—allergic rhinitis	9.22e-05	0.000346	CcSEcCtD
Nilotinib—Dysgeusia—Triamcinolone—allergic rhinitis	9.21e-05	0.000345	CcSEcCtD
Nilotinib—Vertigo—Prednisolone—allergic rhinitis	9.19e-05	0.000344	CcSEcCtD
Nilotinib—Syncope—Prednisolone—allergic rhinitis	9.17e-05	0.000344	CcSEcCtD
Nilotinib—Eye disorder—Dexamethasone—allergic rhinitis	9.16e-05	0.000343	CcSEcCtD
Nilotinib—Eye disorder—Betamethasone—allergic rhinitis	9.16e-05	0.000343	CcSEcCtD
Nilotinib—Back pain—Triamcinolone—allergic rhinitis	9.1e-05	0.000341	CcSEcCtD
Nilotinib—Malaise—Hydrocortisone—allergic rhinitis	9.01e-05	0.000338	CcSEcCtD
Nilotinib—Loss of consciousness—Prednisolone—allergic rhinitis	8.99e-05	0.000337	CcSEcCtD
Nilotinib—Vertigo—Hydrocortisone—allergic rhinitis	8.97e-05	0.000336	CcSEcCtD
Nilotinib—Nausea—Montelukast—allergic rhinitis	8.97e-05	0.000336	CcSEcCtD
Nilotinib—Syncope—Hydrocortisone—allergic rhinitis	8.96e-05	0.000336	CcSEcCtD
Nilotinib—Angiopathy—Betamethasone—allergic rhinitis	8.89e-05	0.000333	CcSEcCtD
Nilotinib—Angiopathy—Dexamethasone—allergic rhinitis	8.89e-05	0.000333	CcSEcCtD
Nilotinib—Hypertension—Prednisolone—allergic rhinitis	8.83e-05	0.000331	CcSEcCtD
Nilotinib—Loss of consciousness—Hydrocortisone—allergic rhinitis	8.78e-05	0.000329	CcSEcCtD
Nilotinib—Arrhythmia—Dexamethasone—allergic rhinitis	8.76e-05	0.000328	CcSEcCtD
Nilotinib—Arrhythmia—Betamethasone—allergic rhinitis	8.76e-05	0.000328	CcSEcCtD
Nilotinib—Ill-defined disorder—Triamcinolone—allergic rhinitis	8.73e-05	0.000327	CcSEcCtD
Nilotinib—Ill-defined disorder—Methylprednisolone—allergic rhinitis	8.71e-05	0.000326	CcSEcCtD
Nilotinib—Alopecia—Dexamethasone—allergic rhinitis	8.66e-05	0.000325	CcSEcCtD
Nilotinib—Alopecia—Betamethasone—allergic rhinitis	8.66e-05	0.000325	CcSEcCtD
Nilotinib—Hypertension—Hydrocortisone—allergic rhinitis	8.62e-05	0.000323	CcSEcCtD
Nilotinib—Discomfort—Prednisolone—allergic rhinitis	8.6e-05	0.000322	CcSEcCtD
Nilotinib—Erythema—Betamethasone—allergic rhinitis	8.53e-05	0.00032	CcSEcCtD
Nilotinib—Erythema—Dexamethasone—allergic rhinitis	8.53e-05	0.00032	CcSEcCtD
Nilotinib—Myalgia—Hydrocortisone—allergic rhinitis	8.5e-05	0.000319	CcSEcCtD
Nilotinib—Malaise—Triamcinolone—allergic rhinitis	8.48e-05	0.000318	CcSEcCtD
Nilotinib—Anxiety—Hydrocortisone—allergic rhinitis	8.47e-05	0.000318	CcSEcCtD
Nilotinib—Malaise—Methylprednisolone—allergic rhinitis	8.46e-05	0.000317	CcSEcCtD
Nilotinib—Vertigo—Triamcinolone—allergic rhinitis	8.45e-05	0.000317	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	8.44e-05	0.000317	CcSEcCtD
Nilotinib—Syncope—Triamcinolone—allergic rhinitis	8.43e-05	0.000316	CcSEcCtD
Nilotinib—Vertigo—Methylprednisolone—allergic rhinitis	8.43e-05	0.000316	CcSEcCtD
Nilotinib—Syncope—Methylprednisolone—allergic rhinitis	8.41e-05	0.000315	CcSEcCtD
Nilotinib—Discomfort—Hydrocortisone—allergic rhinitis	8.4e-05	0.000315	CcSEcCtD
Nilotinib—Oedema—Prednisolone—allergic rhinitis	8.35e-05	0.000313	CcSEcCtD
Nilotinib—Loss of consciousness—Triamcinolone—allergic rhinitis	8.27e-05	0.00031	CcSEcCtD
Nilotinib—Loss of consciousness—Methylprednisolone—allergic rhinitis	8.25e-05	0.000309	CcSEcCtD
Nilotinib—Shock—Prednisolone—allergic rhinitis	8.21e-05	0.000308	CcSEcCtD
Nilotinib—Cough—Triamcinolone—allergic rhinitis	8.21e-05	0.000308	CcSEcCtD
Nilotinib—Oedema—Hydrocortisone—allergic rhinitis	8.15e-05	0.000306	CcSEcCtD
Nilotinib—Tachycardia—Prednisolone—allergic rhinitis	8.15e-05	0.000305	CcSEcCtD
Nilotinib—Hypertension—Triamcinolone—allergic rhinitis	8.12e-05	0.000304	CcSEcCtD
Nilotinib—Hypertension—Methylprednisolone—allergic rhinitis	8.1e-05	0.000304	CcSEcCtD
Nilotinib—Infection—Hydrocortisone—allergic rhinitis	8.1e-05	0.000304	CcSEcCtD
Nilotinib—Hyperhidrosis—Prednisolone—allergic rhinitis	8.07e-05	0.000302	CcSEcCtD
Nilotinib—Shock—Hydrocortisone—allergic rhinitis	8.02e-05	0.000301	CcSEcCtD
Nilotinib—Myalgia—Triamcinolone—allergic rhinitis	8.01e-05	0.0003	CcSEcCtD
Nilotinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	7.99e-05	0.0003	CcSEcCtD
Nilotinib—Arthralgia—Methylprednisolone—allergic rhinitis	7.99e-05	0.000299	CcSEcCtD
Nilotinib—Myalgia—Methylprednisolone—allergic rhinitis	7.99e-05	0.000299	CcSEcCtD
Nilotinib—Anxiety—Methylprednisolone—allergic rhinitis	7.96e-05	0.000298	CcSEcCtD
Nilotinib—Tachycardia—Hydrocortisone—allergic rhinitis	7.96e-05	0.000298	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	7.93e-05	0.000297	CcSEcCtD
Nilotinib—Skin disorder—Hydrocortisone—allergic rhinitis	7.92e-05	0.000297	CcSEcCtD
Nilotinib—Ill-defined disorder—Dexamethasone—allergic rhinitis	7.92e-05	0.000297	CcSEcCtD
Nilotinib—Ill-defined disorder—Betamethasone—allergic rhinitis	7.92e-05	0.000297	CcSEcCtD
Nilotinib—Discomfort—Triamcinolone—allergic rhinitis	7.91e-05	0.000297	CcSEcCtD
Nilotinib—Discomfort—Methylprednisolone—allergic rhinitis	7.89e-05	0.000296	CcSEcCtD
Nilotinib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	7.88e-05	0.000295	CcSEcCtD
Nilotinib—Dry mouth—Triamcinolone—allergic rhinitis	7.83e-05	0.000294	CcSEcCtD
Nilotinib—Anorexia—Hydrocortisone—allergic rhinitis	7.77e-05	0.000291	CcSEcCtD
Nilotinib—Confusional state—Methylprednisolone—allergic rhinitis	7.72e-05	0.000289	CcSEcCtD
Nilotinib—Malaise—Dexamethasone—allergic rhinitis	7.69e-05	0.000288	CcSEcCtD
Nilotinib—Malaise—Betamethasone—allergic rhinitis	7.69e-05	0.000288	CcSEcCtD
Nilotinib—Oedema—Triamcinolone—allergic rhinitis	7.68e-05	0.000288	CcSEcCtD
Nilotinib—Vertigo—Dexamethasone—allergic rhinitis	7.67e-05	0.000287	CcSEcCtD
Nilotinib—Vertigo—Betamethasone—allergic rhinitis	7.67e-05	0.000287	CcSEcCtD
Nilotinib—Syncope—Dexamethasone—allergic rhinitis	7.65e-05	0.000287	CcSEcCtD
Nilotinib—Syncope—Betamethasone—allergic rhinitis	7.65e-05	0.000287	CcSEcCtD
Nilotinib—Infection—Triamcinolone—allergic rhinitis	7.63e-05	0.000286	CcSEcCtD
Nilotinib—Hypotension—Hydrocortisone—allergic rhinitis	7.62e-05	0.000286	CcSEcCtD
Nilotinib—Infection—Methylprednisolone—allergic rhinitis	7.61e-05	0.000285	CcSEcCtD
Nilotinib—Shock—Triamcinolone—allergic rhinitis	7.55e-05	0.000283	CcSEcCtD
Nilotinib—Insomnia—Prednisolone—allergic rhinitis	7.55e-05	0.000283	CcSEcCtD
Nilotinib—Shock—Methylprednisolone—allergic rhinitis	7.53e-05	0.000282	CcSEcCtD
Nilotinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	7.51e-05	0.000282	CcSEcCtD
Nilotinib—Loss of consciousness—Betamethasone—allergic rhinitis	7.5e-05	0.000281	CcSEcCtD
Nilotinib—Loss of consciousness—Dexamethasone—allergic rhinitis	7.5e-05	0.000281	CcSEcCtD
Nilotinib—Paraesthesia—Prednisolone—allergic rhinitis	7.49e-05	0.000281	CcSEcCtD
Nilotinib—Tachycardia—Triamcinolone—allergic rhinitis	7.49e-05	0.000281	CcSEcCtD
Nilotinib—Tachycardia—Methylprednisolone—allergic rhinitis	7.47e-05	0.00028	CcSEcCtD
Nilotinib—Skin disorder—Methylprednisolone—allergic rhinitis	7.44e-05	0.000279	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	7.43e-05	0.000278	CcSEcCtD
Nilotinib—Hyperhidrosis—Triamcinolone—allergic rhinitis	7.42e-05	0.000278	CcSEcCtD
Nilotinib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	7.4e-05	0.000278	CcSEcCtD
Nilotinib—Insomnia—Hydrocortisone—allergic rhinitis	7.37e-05	0.000276	CcSEcCtD
Nilotinib—Hypertension—Betamethasone—allergic rhinitis	7.37e-05	0.000276	CcSEcCtD
Nilotinib—Hypertension—Dexamethasone—allergic rhinitis	7.37e-05	0.000276	CcSEcCtD
Nilotinib—Paraesthesia—Hydrocortisone—allergic rhinitis	7.32e-05	0.000274	CcSEcCtD
Nilotinib—Myalgia—Betamethasone—allergic rhinitis	7.26e-05	0.000272	CcSEcCtD
Nilotinib—Myalgia—Dexamethasone—allergic rhinitis	7.26e-05	0.000272	CcSEcCtD
Nilotinib—Anxiety—Betamethasone—allergic rhinitis	7.24e-05	0.000271	CcSEcCtD
Nilotinib—Anxiety—Dexamethasone—allergic rhinitis	7.24e-05	0.000271	CcSEcCtD
Nilotinib—Discomfort—Dexamethasone—allergic rhinitis	7.18e-05	0.000269	CcSEcCtD
Nilotinib—Discomfort—Betamethasone—allergic rhinitis	7.18e-05	0.000269	CcSEcCtD
Nilotinib—Dyspepsia—Hydrocortisone—allergic rhinitis	7.18e-05	0.000269	CcSEcCtD
Nilotinib—Hypotension—Methylprednisolone—allergic rhinitis	7.16e-05	0.000268	CcSEcCtD
Nilotinib—Pain—Prednisolone—allergic rhinitis	7.14e-05	0.000268	CcSEcCtD
Nilotinib—Decreased appetite—Hydrocortisone—allergic rhinitis	7.09e-05	0.000266	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	7.04e-05	0.000264	CcSEcCtD
Nilotinib—Fatigue—Hydrocortisone—allergic rhinitis	7.03e-05	0.000263	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	6.99e-05	0.000262	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	6.98e-05	0.000262	CcSEcCtD
Nilotinib—Pain—Hydrocortisone—allergic rhinitis	6.97e-05	0.000261	CcSEcCtD
Nilotinib—Oedema—Dexamethasone—allergic rhinitis	6.96e-05	0.000261	CcSEcCtD
Nilotinib—Oedema—Betamethasone—allergic rhinitis	6.96e-05	0.000261	CcSEcCtD
Nilotinib—Insomnia—Triamcinolone—allergic rhinitis	6.94e-05	0.00026	CcSEcCtD
Nilotinib—Insomnia—Methylprednisolone—allergic rhinitis	6.93e-05	0.00026	CcSEcCtD
Nilotinib—Infection—Betamethasone—allergic rhinitis	6.92e-05	0.000259	CcSEcCtD
Nilotinib—Infection—Dexamethasone—allergic rhinitis	6.92e-05	0.000259	CcSEcCtD
Nilotinib—Paraesthesia—Triamcinolone—allergic rhinitis	6.89e-05	0.000258	CcSEcCtD
Nilotinib—Feeling abnormal—Prednisolone—allergic rhinitis	6.88e-05	0.000258	CcSEcCtD
Nilotinib—Paraesthesia—Methylprednisolone—allergic rhinitis	6.88e-05	0.000258	CcSEcCtD
Nilotinib—Shock—Betamethasone—allergic rhinitis	6.85e-05	0.000257	CcSEcCtD
Nilotinib—Shock—Dexamethasone—allergic rhinitis	6.85e-05	0.000257	CcSEcCtD
Nilotinib—Dyspnoea—Triamcinolone—allergic rhinitis	6.84e-05	0.000257	CcSEcCtD
Nilotinib—Nervous system disorder—Betamethasone—allergic rhinitis	6.83e-05	0.000256	CcSEcCtD
Nilotinib—Nervous system disorder—Dexamethasone—allergic rhinitis	6.83e-05	0.000256	CcSEcCtD
Nilotinib—Thrombocytopenia—Betamethasone—allergic rhinitis	6.82e-05	0.000256	CcSEcCtD
Nilotinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	6.82e-05	0.000256	CcSEcCtD
Nilotinib—Tachycardia—Dexamethasone—allergic rhinitis	6.8e-05	0.000255	CcSEcCtD
Nilotinib—Tachycardia—Betamethasone—allergic rhinitis	6.8e-05	0.000255	CcSEcCtD
Nilotinib—Dyspepsia—Triamcinolone—allergic rhinitis	6.76e-05	0.000253	CcSEcCtD
Nilotinib—Dyspepsia—Methylprednisolone—allergic rhinitis	6.74e-05	0.000253	CcSEcCtD
Nilotinib—Hyperhidrosis—Dexamethasone—allergic rhinitis	6.73e-05	0.000252	CcSEcCtD
Nilotinib—Hyperhidrosis—Betamethasone—allergic rhinitis	6.73e-05	0.000252	CcSEcCtD
Nilotinib—Feeling abnormal—Hydrocortisone—allergic rhinitis	6.72e-05	0.000252	CcSEcCtD
Nilotinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	6.67e-05	0.00025	CcSEcCtD
Nilotinib—Anorexia—Betamethasone—allergic rhinitis	6.64e-05	0.000249	CcSEcCtD
Nilotinib—Anorexia—Dexamethasone—allergic rhinitis	6.64e-05	0.000249	CcSEcCtD
Nilotinib—Urticaria—Prednisolone—allergic rhinitis	6.63e-05	0.000249	CcSEcCtD
Nilotinib—Fatigue—Triamcinolone—allergic rhinitis	6.62e-05	0.000248	CcSEcCtD
Nilotinib—Fatigue—Methylprednisolone—allergic rhinitis	6.6e-05	0.000248	CcSEcCtD
Nilotinib—Pain—Triamcinolone—allergic rhinitis	6.56e-05	0.000246	CcSEcCtD
Nilotinib—Hypotension—Dexamethasone—allergic rhinitis	6.51e-05	0.000244	CcSEcCtD
Nilotinib—Hypotension—Betamethasone—allergic rhinitis	6.51e-05	0.000244	CcSEcCtD
Nilotinib—Urticaria—Hydrocortisone—allergic rhinitis	6.48e-05	0.000243	CcSEcCtD
Nilotinib—Abdominal pain—Hydrocortisone—allergic rhinitis	6.44e-05	0.000242	CcSEcCtD
Nilotinib—Body temperature increased—Hydrocortisone—allergic rhinitis	6.44e-05	0.000242	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	6.34e-05	0.000238	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	6.34e-05	0.000238	CcSEcCtD
Nilotinib—Feeling abnormal—Triamcinolone—allergic rhinitis	6.32e-05	0.000237	CcSEcCtD
Nilotinib—Feeling abnormal—Methylprednisolone—allergic rhinitis	6.31e-05	0.000237	CcSEcCtD
Nilotinib—Insomnia—Betamethasone—allergic rhinitis	6.3e-05	0.000236	CcSEcCtD
Nilotinib—Insomnia—Dexamethasone—allergic rhinitis	6.3e-05	0.000236	CcSEcCtD
Nilotinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	6.26e-05	0.000235	CcSEcCtD
Nilotinib—Paraesthesia—Dexamethasone—allergic rhinitis	6.25e-05	0.000234	CcSEcCtD
Nilotinib—Paraesthesia—Betamethasone—allergic rhinitis	6.25e-05	0.000234	CcSEcCtD
Nilotinib—Hypersensitivity—Prednisolone—allergic rhinitis	6.15e-05	0.000231	CcSEcCtD
Nilotinib—Dyspepsia—Betamethasone—allergic rhinitis	6.13e-05	0.00023	CcSEcCtD
Nilotinib—Dyspepsia—Dexamethasone—allergic rhinitis	6.13e-05	0.00023	CcSEcCtD
Nilotinib—Urticaria—Triamcinolone—allergic rhinitis	6.1e-05	0.000229	CcSEcCtD
Nilotinib—Urticaria—Methylprednisolone—allergic rhinitis	6.08e-05	0.000228	CcSEcCtD
Nilotinib—Body temperature increased—Triamcinolone—allergic rhinitis	6.07e-05	0.000227	CcSEcCtD
Nilotinib—Abdominal pain—Methylprednisolone—allergic rhinitis	6.05e-05	0.000227	CcSEcCtD
Nilotinib—Decreased appetite—Dexamethasone—allergic rhinitis	6.05e-05	0.000227	CcSEcCtD
Nilotinib—Decreased appetite—Betamethasone—allergic rhinitis	6.05e-05	0.000227	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	6.01e-05	0.000225	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	6.01e-05	0.000225	CcSEcCtD
Nilotinib—Hypersensitivity—Hydrocortisone—allergic rhinitis	6.01e-05	0.000225	CcSEcCtD
Nilotinib—Fatigue—Betamethasone—allergic rhinitis	6e-05	0.000225	CcSEcCtD
Nilotinib—Fatigue—Dexamethasone—allergic rhinitis	6e-05	0.000225	CcSEcCtD
Nilotinib—Pain—Dexamethasone—allergic rhinitis	5.96e-05	0.000223	CcSEcCtD
Nilotinib—Pain—Betamethasone—allergic rhinitis	5.96e-05	0.000223	CcSEcCtD
Nilotinib—Asthenia—Hydrocortisone—allergic rhinitis	5.85e-05	0.000219	CcSEcCtD
Nilotinib—Pruritus—Hydrocortisone—allergic rhinitis	5.77e-05	0.000216	CcSEcCtD
Nilotinib—Feeling abnormal—Betamethasone—allergic rhinitis	5.74e-05	0.000215	CcSEcCtD
Nilotinib—Feeling abnormal—Dexamethasone—allergic rhinitis	5.74e-05	0.000215	CcSEcCtD
Nilotinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	5.69e-05	0.000213	CcSEcCtD
Nilotinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	5.69e-05	0.000213	CcSEcCtD
Nilotinib—Hypersensitivity—Triamcinolone—allergic rhinitis	5.65e-05	0.000212	CcSEcCtD
Nilotinib—Hypersensitivity—Methylprednisolone—allergic rhinitis	5.64e-05	0.000212	CcSEcCtD
Nilotinib—Diarrhoea—Hydrocortisone—allergic rhinitis	5.58e-05	0.000209	CcSEcCtD
Nilotinib—Urticaria—Betamethasone—allergic rhinitis	5.53e-05	0.000207	CcSEcCtD
Nilotinib—Urticaria—Dexamethasone—allergic rhinitis	5.53e-05	0.000207	CcSEcCtD
Nilotinib—Dizziness—Prednisolone—allergic rhinitis	5.52e-05	0.000207	CcSEcCtD
Nilotinib—Asthenia—Triamcinolone—allergic rhinitis	5.51e-05	0.000206	CcSEcCtD
Nilotinib—Abdominal pain—Betamethasone—allergic rhinitis	5.51e-05	0.000206	CcSEcCtD
Nilotinib—Body temperature increased—Dexamethasone—allergic rhinitis	5.51e-05	0.000206	CcSEcCtD
Nilotinib—Abdominal pain—Dexamethasone—allergic rhinitis	5.51e-05	0.000206	CcSEcCtD
Nilotinib—Body temperature increased—Betamethasone—allergic rhinitis	5.51e-05	0.000206	CcSEcCtD
Nilotinib—Asthenia—Methylprednisolone—allergic rhinitis	5.49e-05	0.000206	CcSEcCtD
Nilotinib—Pruritus—Triamcinolone—allergic rhinitis	5.43e-05	0.000204	CcSEcCtD
Nilotinib—Pruritus—Methylprednisolone—allergic rhinitis	5.42e-05	0.000203	CcSEcCtD
Nilotinib—Dizziness—Hydrocortisone—allergic rhinitis	5.39e-05	0.000202	CcSEcCtD
Nilotinib—Rash—Prednisolone—allergic rhinitis	5.26e-05	0.000197	CcSEcCtD
Nilotinib—Dermatitis—Prednisolone—allergic rhinitis	5.26e-05	0.000197	CcSEcCtD
Nilotinib—Diarrhoea—Methylprednisolone—allergic rhinitis	5.24e-05	0.000196	CcSEcCtD
Nilotinib—Headache—Prednisolone—allergic rhinitis	5.23e-05	0.000196	CcSEcCtD
Nilotinib—Vomiting—Hydrocortisone—allergic rhinitis	5.18e-05	0.000194	CcSEcCtD
Nilotinib—Rash—Hydrocortisone—allergic rhinitis	5.14e-05	0.000193	CcSEcCtD
Nilotinib—Dermatitis—Hydrocortisone—allergic rhinitis	5.13e-05	0.000193	CcSEcCtD
Nilotinib—Headache—Hydrocortisone—allergic rhinitis	5.11e-05	0.000191	CcSEcCtD
Nilotinib—Dizziness—Triamcinolone—allergic rhinitis	5.08e-05	0.00019	CcSEcCtD
Nilotinib—Dizziness—Methylprednisolone—allergic rhinitis	5.06e-05	0.00019	CcSEcCtD
Nilotinib—Asthenia—Dexamethasone—allergic rhinitis	5e-05	0.000187	CcSEcCtD
Nilotinib—Asthenia—Betamethasone—allergic rhinitis	5e-05	0.000187	CcSEcCtD
Nilotinib—Nausea—Prednisolone—allergic rhinitis	4.96e-05	0.000186	CcSEcCtD
Nilotinib—Pruritus—Dexamethasone—allergic rhinitis	4.93e-05	0.000185	CcSEcCtD
Nilotinib—Pruritus—Betamethasone—allergic rhinitis	4.93e-05	0.000185	CcSEcCtD
Nilotinib—Vomiting—Triamcinolone—allergic rhinitis	4.88e-05	0.000183	CcSEcCtD
Nilotinib—Vomiting—Methylprednisolone—allergic rhinitis	4.87e-05	0.000183	CcSEcCtD
Nilotinib—Nausea—Hydrocortisone—allergic rhinitis	4.84e-05	0.000182	CcSEcCtD
Nilotinib—Rash—Triamcinolone—allergic rhinitis	4.84e-05	0.000181	CcSEcCtD
Nilotinib—Dermatitis—Triamcinolone—allergic rhinitis	4.83e-05	0.000181	CcSEcCtD
Nilotinib—Rash—Methylprednisolone—allergic rhinitis	4.83e-05	0.000181	CcSEcCtD
Nilotinib—Dermatitis—Methylprednisolone—allergic rhinitis	4.82e-05	0.000181	CcSEcCtD
Nilotinib—Headache—Triamcinolone—allergic rhinitis	4.81e-05	0.00018	CcSEcCtD
Nilotinib—Headache—Methylprednisolone—allergic rhinitis	4.8e-05	0.00018	CcSEcCtD
Nilotinib—Diarrhoea—Betamethasone—allergic rhinitis	4.76e-05	0.000179	CcSEcCtD
Nilotinib—Diarrhoea—Dexamethasone—allergic rhinitis	4.76e-05	0.000179	CcSEcCtD
Nilotinib—EPHB2—Developmental Biology—TGFB1—allergic rhinitis	4.76e-05	0.000351	CbGpPWpGaD
Nilotinib—PDGFRB—B Cell Activation—NFKB1—allergic rhinitis	4.71e-05	0.000348	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-G—allergic rhinitis	4.68e-05	0.000346	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.67e-05	0.000345	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—TGFB1—allergic rhinitis	4.62e-05	0.000341	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TGFB1—allergic rhinitis	4.62e-05	0.000341	CbGpPWpGaD
Nilotinib—LYN—B Cell Activation—NFKB1—allergic rhinitis	4.61e-05	0.000341	CbGpPWpGaD
Nilotinib—Dizziness—Dexamethasone—allergic rhinitis	4.61e-05	0.000173	CcSEcCtD
Nilotinib—Dizziness—Betamethasone—allergic rhinitis	4.61e-05	0.000173	CcSEcCtD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.56e-05	0.000337	CbGpPWpGaD
Nilotinib—Nausea—Triamcinolone—allergic rhinitis	4.56e-05	0.000171	CcSEcCtD
Nilotinib—Nausea—Methylprednisolone—allergic rhinitis	4.55e-05	0.000171	CcSEcCtD
Nilotinib—MAPK14—Cellular Senescence—NFKB1—allergic rhinitis	4.54e-05	0.000335	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—TGFB1—allergic rhinitis	4.53e-05	0.000335	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PTGDR2—allergic rhinitis	4.51e-05	0.000334	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—NFKB1—allergic rhinitis	4.51e-05	0.000333	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQB1—allergic rhinitis	4.49e-05	0.000332	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	4.47e-05	0.00033	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—NFKB1—allergic rhinitis	4.47e-05	0.00033	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.45e-05	0.000328	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-G—allergic rhinitis	4.43e-05	0.000328	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.43e-05	0.000327	CbGpPWpGaD
Nilotinib—Vomiting—Dexamethasone—allergic rhinitis	4.43e-05	0.000166	CcSEcCtD
Nilotinib—Vomiting—Betamethasone—allergic rhinitis	4.43e-05	0.000166	CcSEcCtD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.42e-05	0.000327	CbGpPWpGaD
Nilotinib—Rash—Betamethasone—allergic rhinitis	4.39e-05	0.000165	CcSEcCtD
Nilotinib—Rash—Dexamethasone—allergic rhinitis	4.39e-05	0.000165	CcSEcCtD
Nilotinib—Dermatitis—Betamethasone—allergic rhinitis	4.39e-05	0.000164	CcSEcCtD
Nilotinib—Dermatitis—Dexamethasone—allergic rhinitis	4.39e-05	0.000164	CcSEcCtD
Nilotinib—Headache—Betamethasone—allergic rhinitis	4.36e-05	0.000164	CcSEcCtD
Nilotinib—Headache—Dexamethasone—allergic rhinitis	4.36e-05	0.000164	CcSEcCtD
Nilotinib—EPHA6—Developmental Biology—TGFB1—allergic rhinitis	4.34e-05	0.000321	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—SMAD3—allergic rhinitis	4.31e-05	0.000319	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—SMAD3—allergic rhinitis	4.29e-05	0.000317	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	4.28e-05	0.000316	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL5—allergic rhinitis	4.19e-05	0.000309	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CYSLTR1—allergic rhinitis	4.15e-05	0.000307	CbGpPWpGaD
Nilotinib—Nausea—Dexamethasone—allergic rhinitis	4.14e-05	0.000155	CcSEcCtD
Nilotinib—Nausea—Betamethasone—allergic rhinitis	4.14e-05	0.000155	CcSEcCtD
Nilotinib—HCK—Innate Immune System—CD4—allergic rhinitis	4.14e-05	0.000306	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CYSLTR1—allergic rhinitis	4.11e-05	0.000304	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.11e-05	0.000304	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.1e-05	0.000303	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—SMAD3—allergic rhinitis	4.09e-05	0.000302	CbGpPWpGaD
Nilotinib—LCK—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	4.09e-05	0.000302	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQB1—allergic rhinitis	4.07e-05	0.000301	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQB1—allergic rhinitis	4.07e-05	0.000301	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTGDR2—allergic rhinitis	4.07e-05	0.0003	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—NFKB1—allergic rhinitis	4.07e-05	0.0003	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQB1—allergic rhinitis	4.06e-05	0.0003	CbGpPWpGaD
Nilotinib—LCK—HIV Infection—CD4—allergic rhinitis	4.04e-05	0.000299	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.02e-05	0.000297	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCL11—allergic rhinitis	4.01e-05	0.000296	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TGFB1—allergic rhinitis	4e-05	0.000296	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-G—allergic rhinitis	4e-05	0.000295	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTGDR2—allergic rhinitis	3.98e-05	0.000294	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCL11—allergic rhinitis	3.97e-05	0.000293	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-G—allergic rhinitis	3.91e-05	0.000289	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-G—allergic rhinitis	3.89e-05	0.000288	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.89e-05	0.000287	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—NFKB1—allergic rhinitis	3.85e-05	0.000284	CbGpPWpGaD
Nilotinib—LCK—B Cell Activation—NFKB1—allergic rhinitis	3.78e-05	0.000279	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL5—allergic rhinitis	3.78e-05	0.000279	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTGDR2—allergic rhinitis	3.77e-05	0.000279	CbGpPWpGaD
Nilotinib—HCK—Disease—SMAD3—allergic rhinitis	3.77e-05	0.000278	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—CD4—allergic rhinitis	3.75e-05	0.000277	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CYSLTR1—allergic rhinitis	3.74e-05	0.000276	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—CD4—allergic rhinitis	3.73e-05	0.000276	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-G—allergic rhinitis	3.71e-05	0.000274	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.7e-05	0.000274	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TAC1—allergic rhinitis	3.66e-05	0.00027	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCL11—allergic rhinitis	3.61e-05	0.000267	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—CD4—allergic rhinitis	3.6e-05	0.000266	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL5—allergic rhinitis	3.57e-05	0.000264	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—NFKB1—allergic rhinitis	3.56e-05	0.000263	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CYSLTR1—allergic rhinitis	3.54e-05	0.000262	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—ICAM1—allergic rhinitis	3.52e-05	0.00026	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.48e-05	0.000257	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TAC1—allergic rhinitis	3.48e-05	0.000257	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—NFKB1—allergic rhinitis	3.47e-05	0.000256	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	3.45e-05	0.000255	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—NFKB1—allergic rhinitis	3.43e-05	0.000254	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCL11—allergic rhinitis	3.42e-05	0.000253	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	3.4e-05	0.000251	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL5—allergic rhinitis	3.4e-05	0.000251	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—ICAM1—allergic rhinitis	3.33e-05	0.000246	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.3e-05	0.000244	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.3e-05	0.000243	CbGpPWpGaD
Nilotinib—HCK—Immune System—ICAM1—allergic rhinitis	3.28e-05	0.000242	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTGDR2—allergic rhinitis	3.26e-05	0.000241	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQB1—allergic rhinitis	3.24e-05	0.00024	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL5—allergic rhinitis	3.23e-05	0.000239	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—NFKB1—allergic rhinitis	3.23e-05	0.000239	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL5—allergic rhinitis	3.22e-05	0.000238	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—NFKB1—allergic rhinitis	3.22e-05	0.000238	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—NFKB1—allergic rhinitis	3.22e-05	0.000238	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-G—allergic rhinitis	3.21e-05	0.000237	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CYSLTR1—allergic rhinitis	3.19e-05	0.000236	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL5—allergic rhinitis	3.15e-05	0.000233	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL5—allergic rhinitis	3.14e-05	0.000232	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CYSLTR1—allergic rhinitis	3.12e-05	0.000231	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—NFKB1—allergic rhinitis	3.1e-05	0.000229	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL11—allergic rhinitis	3.08e-05	0.000228	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL11—allergic rhinitis	3.02e-05	0.000223	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—ICAM1—allergic rhinitis	3e-05	0.000222	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL5—allergic rhinitis	2.99e-05	0.000221	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—CD4—allergic rhinitis	2.99e-05	0.000221	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TGFB1—allergic rhinitis	2.98e-05	0.00022	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—ICAM1—allergic rhinitis	2.97e-05	0.000219	CbGpPWpGaD
Nilotinib—BLK—Immune System—ICAM1—allergic rhinitis	2.97e-05	0.000219	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CYSLTR1—allergic rhinitis	2.96e-05	0.000219	CbGpPWpGaD
Nilotinib—FGR—Immune System—ICAM1—allergic rhinitis	2.96e-05	0.000219	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—ICAM1—allergic rhinitis	2.94e-05	0.000217	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—SMAD3—allergic rhinitis	2.93e-05	0.000217	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQB1—allergic rhinitis	2.92e-05	0.000216	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—NFKB1—allergic rhinitis	2.91e-05	0.000215	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TAC1—allergic rhinitis	2.91e-05	0.000215	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TAC1—allergic rhinitis	2.89e-05	0.000213	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL11—allergic rhinitis	2.86e-05	0.000211	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.85e-05	0.000211	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	2.83e-05	0.000209	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—NFKB1—allergic rhinitis	2.78e-05	0.000206	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQB1—allergic rhinitis	2.77e-05	0.000204	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL5—allergic rhinitis	2.71e-05	0.0002	CbGpPWpGaD
Nilotinib—BRAF—Disease—SMAD3—allergic rhinitis	2.7e-05	0.000199	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—CD4—allergic rhinitis	2.69e-05	0.000199	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL5—allergic rhinitis	2.68e-05	0.000198	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TAC1—allergic rhinitis	2.63e-05	0.000194	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD4—allergic rhinitis	2.59e-05	0.000191	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL5—allergic rhinitis	2.58e-05	0.000191	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—NFKB1—allergic rhinitis	2.57e-05	0.00019	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CYSLTR1—allergic rhinitis	2.56e-05	0.000189	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CD4—allergic rhinitis	2.55e-05	0.000188	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQB1—allergic rhinitis	2.49e-05	0.000184	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TAC1—allergic rhinitis	2.49e-05	0.000184	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL11—allergic rhinitis	2.47e-05	0.000183	CbGpPWpGaD
Nilotinib—KIT—Disease—SMAD3—allergic rhinitis	2.45e-05	0.000181	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD4—allergic rhinitis	2.45e-05	0.000181	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL5—allergic rhinitis	2.44e-05	0.00018	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQB1—allergic rhinitis	2.44e-05	0.00018	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	2.43e-05	0.00018	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TGFB1—allergic rhinitis	2.43e-05	0.000179	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD4—allergic rhinitis	2.41e-05	0.000178	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—ICAM1—allergic rhinitis	2.41e-05	0.000178	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SMAD3—allergic rhinitis	2.39e-05	0.000177	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—ICAM1—allergic rhinitis	2.37e-05	0.000175	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—SMAD3—allergic rhinitis	2.32e-05	0.000172	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—NFKB1—allergic rhinitis	2.32e-05	0.000171	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQB1—allergic rhinitis	2.31e-05	0.000171	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL5—allergic rhinitis	2.31e-05	0.000171	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD4—allergic rhinitis	2.3e-05	0.00017	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SMAD3—allergic rhinitis	2.27e-05	0.000168	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD4—allergic rhinitis	2.25e-05	0.000166	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TAC1—allergic rhinitis	2.24e-05	0.000165	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD4—allergic rhinitis	2.24e-05	0.000165	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—NFKB1—allergic rhinitis	2.23e-05	0.000165	CbGpPWpGaD
Nilotinib—HCK—Disease—CD4—allergic rhinitis	2.22e-05	0.000164	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD4—allergic rhinitis	2.2e-05	0.000163	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—NFKB1—allergic rhinitis	2.2e-05	0.000162	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—NFKB1—allergic rhinitis	2.19e-05	0.000162	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TAC1—allergic rhinitis	2.19e-05	0.000162	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	2.18e-05	0.000161	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD4—allergic rhinitis	2.18e-05	0.000161	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD4—allergic rhinitis	2.18e-05	0.000161	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD4—allergic rhinitis	2.18e-05	0.000161	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD4—allergic rhinitis	2.16e-05	0.000159	CbGpPWpGaD
Nilotinib—KIT—Immune System—ICAM1—allergic rhinitis	2.13e-05	0.000158	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD4—allergic rhinitis	2.13e-05	0.000157	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—NFKB1—allergic rhinitis	2.11e-05	0.000156	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—SMAD3—allergic rhinitis	2.09e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—SMAD3—allergic rhinitis	2.09e-05	0.000155	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL5—allergic rhinitis	2.08e-05	0.000154	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—NFKB1—allergic rhinitis	2.08e-05	0.000154	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TAC1—allergic rhinitis	2.08e-05	0.000154	CbGpPWpGaD
Nilotinib—HCK—Immune System—NFKB1—allergic rhinitis	2.08e-05	0.000153	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL5—allergic rhinitis	2.04e-05	0.000151	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—ICAM1—allergic rhinitis	2.02e-05	0.000149	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.01e-05	0.000149	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQB1—allergic rhinitis	2e-05	0.000148	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—NFKB1—allergic rhinitis	1.98e-05	0.000146	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—NFKB1—allergic rhinitis	1.94e-05	0.000143	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL5—allergic rhinitis	1.93e-05	0.000143	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	1.93e-05	0.000142	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SMAD3—allergic rhinitis	1.91e-05	0.000141	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—NFKB1—allergic rhinitis	1.9e-05	0.00014	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SMAD3—allergic rhinitis	1.89e-05	0.000139	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—NFKB1—allergic rhinitis	1.88e-05	0.000139	CbGpPWpGaD
Nilotinib—BLK—Immune System—NFKB1—allergic rhinitis	1.88e-05	0.000139	CbGpPWpGaD
Nilotinib—FGR—Immune System—NFKB1—allergic rhinitis	1.87e-05	0.000138	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—NFKB1—allergic rhinitis	1.86e-05	0.000137	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD4—allergic rhinitis	1.84e-05	0.000136	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—NFKB1—allergic rhinitis	1.84e-05	0.000136	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TGFB1—allergic rhinitis	1.83e-05	0.000135	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—ICAM1—allergic rhinitis	1.82e-05	0.000134	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	1.82e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TAC1—allergic rhinitis	1.8e-05	0.000133	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TGFB1—allergic rhinitis	1.79e-05	0.000132	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	1.78e-05	0.000132	CbGpPWpGaD
Nilotinib—LYN—Immune System—ICAM1—allergic rhinitis	1.78e-05	0.000132	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ICAM1—allergic rhinitis	1.77e-05	0.000131	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD4—allergic rhinitis	1.77e-05	0.000131	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD4—allergic rhinitis	1.74e-05	0.000128	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TGFB1—allergic rhinitis	1.73e-05	0.000128	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SMAD3—allergic rhinitis	1.72e-05	0.000127	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TGFB1—allergic rhinitis	1.7e-05	0.000125	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ICAM1—allergic rhinitis	1.69e-05	0.000125	CbGpPWpGaD
Nilotinib—LCK—Disease—SMAD3—allergic rhinitis	1.68e-05	0.000124	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.68e-05	0.000124	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL5—allergic rhinitis	1.67e-05	0.000123	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SMAD3—allergic rhinitis	1.63e-05	0.00012	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFB1—allergic rhinitis	1.6e-05	0.000118	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD4—allergic rhinitis	1.59e-05	0.000118	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—NFKB1—allergic rhinitis	1.59e-05	0.000117	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD4—allergic rhinitis	1.57e-05	0.000116	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—NFKB1—allergic rhinitis	1.52e-05	0.000113	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—NFKB1—allergic rhinitis	1.5e-05	0.000111	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD4—allergic rhinitis	1.48e-05	0.00011	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TGFB1—allergic rhinitis	1.47e-05	0.000109	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SMAD3—allergic rhinitis	1.47e-05	0.000108	CbGpPWpGaD
Nilotinib—LCK—Immune System—ICAM1—allergic rhinitis	1.46e-05	0.000108	CbGpPWpGaD
Nilotinib—KIT—Disease—CD4—allergic rhinitis	1.45e-05	0.000107	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SMAD3—allergic rhinitis	1.43e-05	0.000106	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD4—allergic rhinitis	1.37e-05	0.000101	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SMAD3—allergic rhinitis	1.36e-05	0.0001	CbGpPWpGaD
Nilotinib—KIT—Immune System—NFKB1—allergic rhinitis	1.35e-05	9.98e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD4—allergic rhinitis	1.34e-05	9.88e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD4—allergic rhinitis	1.31e-05	9.67e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD4—allergic rhinitis	1.3e-05	9.63e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—NFKB1—allergic rhinitis	1.28e-05	9.45e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD4—allergic rhinitis	1.24e-05	9.17e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD4—allergic rhinitis	1.23e-05	9.12e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NFKB1—allergic rhinitis	1.22e-05	8.98e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SMAD3—allergic rhinitis	1.18e-05	8.69e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NFKB1—allergic rhinitis	1.16e-05	8.54e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—NFKB1—allergic rhinitis	1.15e-05	8.51e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—allergic rhinitis	1.14e-05	8.43e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—NFKB1—allergic rhinitis	1.13e-05	8.33e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—NFKB1—allergic rhinitis	1.12e-05	8.29e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—allergic rhinitis	1.07e-05	7.93e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NFKB1—allergic rhinitis	1.07e-05	7.9e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—allergic rhinitis	1.04e-05	7.68e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—allergic rhinitis	1.01e-05	7.48e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—allergic rhinitis	9.91e-06	7.32e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—allergic rhinitis	9.84e-06	7.27e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NFKB1—allergic rhinitis	9.69e-06	7.16e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—allergic rhinitis	9.63e-06	7.11e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NFKB1—allergic rhinitis	9.6e-06	7.09e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—NFKB1—allergic rhinitis	9.25e-06	6.83e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—allergic rhinitis	8.86e-06	6.55e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NFKB1—allergic rhinitis	8.73e-06	6.45e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NFKB1—allergic rhinitis	8.27e-06	6.11e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—allergic rhinitis	8.07e-06	5.96e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—allergic rhinitis	7.99e-06	5.91e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NFKB1—allergic rhinitis	7.45e-06	5.5e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NFKB1—allergic rhinitis	7.29e-06	5.39e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—allergic rhinitis	7.28e-06	5.38e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—allergic rhinitis	7.11e-06	5.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NFKB1—allergic rhinitis	6.91e-06	5.11e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—allergic rhinitis	6.89e-06	5.09e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—allergic rhinitis	6.2e-06	4.58e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—allergic rhinitis	6.07e-06	4.49e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NFKB1—allergic rhinitis	5.98e-06	4.42e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—allergic rhinitis	5.76e-06	4.25e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—allergic rhinitis	4.98e-06	3.68e-05	CbGpPWpGaD
